Company intelligence / Profile preview

Sustained Therapeutics

Vancouver, British Columbia, Canadasustainedtherapeutics.com ↗

Ownership: Private
Development stage: Phase 2

Overview

The company’s lead product, a locally injected non-opioid sustained-release pain medication, has demonstrated safety and efficacy in a completed Phase I trial with up to four weeks of relief from a single dose. Two Phase II studies are ongoing—one in acute postoperative pain and one in chronic pain—with interim data showing positive results. A second product using the same platform has entered Phase II trials for UTUC cancer as an orphan indication.

Therapeutic areas: OncologyNeurology
Modalities: Sustained-release drug delivery (polymer gel platform)Small molecules (e.g., lidocaine, chemotherapeutic agents)
Industry: Biotech

Drug pipeline

1 asset

lidocaine sustained release

Phase 2

Indications: Post-operative pain, Chronic scrotal pain

Partnerships

No major pharma partnerships disclosed as of latest updates. Four unlicensed products available for licensing discussions.

Beyond the preview

Go deeper on Sustained Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sustained Therapeutics.

Explore the full profile